Filter
2651
Filtered Results: 2651
Text search:
Global
Drug
Facility
Featured
Recommendations
258
New Publications
867
Language
Document type
No document type
1666
Guidelines
352
Studies & Reports
349
Manuals
112
Strategic & Response Plan
91
Training Material
31
Fact sheets
26
Situation Updates
13
Resource Platforms
6
Infographics
3
Brochures
1
App
1
Countries / Regions
India
135
Kenya
98
Ethiopia
84
Global
76
Nigeria
75
Uganda
73
South Africa
71
Tanzania
62
Malawi
59
Nepal
58
Liberia
57
Zambia
50
Sierra Leone
49
Ghana
47
Bangladesh
40
Western and Central Europe
40
Myanmar / Burma
39
Rwanda
36
Africa
35
Namibia
33
Eastern Europe
28
Ukraine
27
Zimbabwe
25
Cambodia
25
Lesotho
25
Asia
25
Philippines
23
Latin America and the Carribbean
23
South–East Asia Region
17
Syria
16
Burkina Faso
15
Senegal
15
Congo, Democratic Republic of
15
Indonesia
15
Mozambique
15
Botswana
15
Russia
12
Cameroon
11
East and Southern Africa
10
Eswatini/ Swaziland
9
Pakistan
8
South Sudan
8
West and Central Africa
7
Middle East and North Africa
7
Haiti
6
Benin
6
Tajikistan
6
Guinea
5
Sudan
5
Colombia
5
Yemen
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Venezuela
5
Laos
5
Afghanistan
4
Germany
4
Thailand
4
China
4
El Salvador
4
Mexico
4
Sri Lanka
4
Somalia
3
Central African Republic
3
Peru
3
Brazil
3
Libya
3
Palestine
3
Moldova
3
Georgia
3
Vietnam
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Iraq
2
Jordan
2
Lebanon
2
Papua New Guinea
2
North Macedonia
2
Madagascar
2
Chile
2
Bhutan
2
Albania
2
Armenia
2
Timor Leste/ East Timor
2
Iran
2
Gabon
2
France
2
Morocco
1
Saudi Arabia
1
Niger
1
Turkey
1
Gambia
1
Ireland
1
Argentina
1
Serbia
1
Ecuador
1
Greece
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1205
Clinical Guidelines
237
Public Health
126
Women & Child Health
112
Key Resources
77
Capacity Building
47
Pharmacy & Technologies
36
Toolboxes
TB
337
HIV
295
AMR
156
COVID-19
125
Mental Health
95
Pharmacy
75
NTDs
60
Caregiver
55
Rapid Response
54
NCDs
40
Conflict
35
Ebola
33
Planetary Health
29
Refugee
27
Global Health Education
22
Disability
21
Health Financing Toolbox
20
Polio
14
Cholera
9
Natural Hazards
9
Specific Hazards
6
Zika
3
Social Ethics
2
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
What countries need: Investments needed for 2010 targets
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
People with disabilities experience significant health inequalities. In Malawi, where most individuals live in low-income rural settings, many of these inequalities are exacerbated by restricted access to health care services. This qualitative study explores the barriers to health care access experi...
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasises the role of preexposure prophylaxis (PrEP) in ...
